A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of Etoreat (Etodolac-Lidocaine Topical Patch) in the Treatment of Acute Low Back Pain

Trial Profile

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of Etoreat (Etodolac-Lidocaine Topical Patch) in the Treatment of Acute Low Back Pain

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Etodolac/lidocaine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Sponsors IL Pharma
  • Most Recent Events

    • 06 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Nov 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 29 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top